Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Trial Profile

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 26 May 2017

At a glance

  • Drugs Tenecteplase (Primary) ; Alteplase
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms ATTEST 2
  • Most Recent Events

    • 21 Sep 2016 Planned initiation date changed from 1 Aug 2016 to 1 Oct 2016.
    • 08 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top